Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Monitoring advanced gastrointestinal stromal tumor with circulating tumor DNA.

Current opinion in oncology - 1 Jul 2024

Gómez-Peregrina David, Cicala Carlo Maria, Serrano César

Abstract excerpt

PURPOSE OF REVIEW: This review explores the role of circulating tumor (ct)DNA as a biomarker for clinical decision-making and monitoring purposes in metastatic gastrointestinal stromal tumor (GIST) patients. We discuss key insights from recent clinical trials and anticipate the future perspectives of ctDNA profiling within the clinical landscape of GIST. RECENT FINDINGS: The identification and molecular...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Circulating Tumor DNA
Share to Gastrointestinal Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gastrointestinal Stromal Tumors

Share to Mutation

Share to Protein Kinase Inhibitors

Share to Randomized Controlled Trials as Topic

Source

Identifiers

PMID: 38726808
DOI: 10.1097/CCO.0000000000001040

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Monitoring advanced gastrointestinal stromal tumor with circulating tumor DNA.PMID 38726808Read ↗

Utility of Circulating Tumor DNA in the Management of Patients With GI Stromal Tumor: Analysis of 243 PatientsSemantic proximity Read ↗

Noninvasive Detection of ctDNA Reveals Intratumor Heterogeneity and Is Associated with Tumor Burden in Gastrointestinal Stromal Tumor.Semantic proximity Read ↗

Clinical value of next generation sequencing of plasma cell-free DNA in gastrointestinal stromal tumors.Semantic proximity Read ↗

Circulating tumor DNA in advanced solid tumors: Clinical relevance and future directions.Semantic proximity Read ↗

Ongoing Clinical Trials and Future Research Scenarios of Circulating Tumor DNA for the Treatment of Metastatic Colorectal Cancer.Semantic proximity Read ↗

Detection of KIT and PDGFRA mutations in the plasma of patients with gastrointestinal stromal tumor.Semantic proximity Read ↗

Latest advances in adult gastrointestinal stromal tumors.Semantic proximity Read ↗

Circulating tumor DNA analysis of the phase III VOYAGER trial: KIT mutational landscape and outcomes in patients with advanced gastrointestinal stromal tumor treated with avapritinib or regorafenib.Semantic proximity Read ↗

Genomic profiling in GIST: Implications in clinical outcome and future challenges.Semantic proximity Read ↗

Clinical Application of Circulating Tumor DNA in the Genetic Analysis of Patients with Advanced GISTSemantic proximity Read ↗

Detecting Primary KIT Mutations in Presurgical Plasma of Patients with Gastrointestinal Stromal Tumor.Semantic proximity Read ↗

Pre-and Postoperative Circulating Tumour DNA in Patients With Gastrointestinal Stromal Tumour - A Methodological Assessment Study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.